English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 157 | Tables: 159 | Service & Software
In 2024, the global market size of Clinical Trial Imaging was estimated to be worth US$ 1569 million and is forecast to reach approximately US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
Global core clinical trial imaging manufacturers include Clario, ICON, McLaren, Calyx and BioTelemetry. The top 5 companies hold a share about 60%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific both with the share about 27%. In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of the subjects are fully protected and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of the trial results.
Clinical trial imaging plays an important role at different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and treatment effect evaluation. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Trial Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Clinical Trial Imaging in global and regional level.
Chapter 3: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Imaging revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Clinical Trial Imaging Product Introduction
1.2 Market by Type
1.2.1 Global Clinical Trial Imaging Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 Market by Application
1.3.1 Global Clinical Trial Imaging Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Clinical Trial Imaging Market Size Estimates and Forecasts
2.2 Clinical Trial Imaging Market Size by Region: 2024 Versus 2031
2.2.1 Global Clinical Trial Imaging Revenue by Region: 2020-2025
2.2.2 Global Clinical Trial Imaging Revenue Forecast by Region (2026-2031)
2.2.3 Global Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Clinical Trial Imaging Revenue by Type (2020-2031)
3.1.2 Global Clinical Trial Imaging Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Clinical Trial Imaging Revenue by Application (2020-2031)
3.2.2 Global Clinical Trial Imaging Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 In-house Imaging Service of Clinical Trial Imaging Revenue Market Share by Application
3.3.2 Central Imaging Service of Clinical Trial Imaging Revenue Market Share by Application
4 Global Clinical Trial Imaging by Company
4.1 Global Clinical Trial Imaging Revenue by Company (2020-2025)
4.2 Global Clinical Trial Imaging Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Clinical Trial Imaging Companies around the World: Ranking by Revenue
4.3.2 Global Clinical Trial Imaging Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Clinical Trial Imaging Companies Headquarters & Product Type
4.4.1 Global Clinical Trial Imaging Companies Headquarters
4.4.2 Date of International Companies Enter into Clinical Trial Imaging Market
4.4.3 Global Clinical Trial Imaging Companies Product & Service
4.4.4 In-house Imaging Service Revenue Market Share of Clinical Trial Imaging by Company
4.4.5 Central Imaging Service Revenue Market Share of Clinical Trial Imaging by Company
4.5 Global Clinical Trial Imaging Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 ICON
5.1.1 ICON Corporation Information
5.1.2 ICON Description, Business Overview
5.1.3 ICON Clinical Trial Imaging Products Offered
5.1.4 ICON Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.1.5 ICON Clinical Trial Imaging Revenue by Product in 2024
5.1.6 ICON Clinical Trial Imaging Revenue by Application in 2024
5.1.7 ICON Clinical Trial Imaging Revenue by Geographic Area in 2024
5.1.8 ICON Recent Developments
5.2 ERT
5.2.1 ERT Corporation Information
5.2.2 ERT Description, Business Overview
5.2.3 ERT Clinical Trial Imaging Products Offered
5.2.4 ERT Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.2.5 ERT Clinical Trial Imaging Revenue by Product in 2024
5.2.6 ERT Clinical Trial Imaging Revenue by Application in 2024
5.2.7 ERT Clinical Trial Imaging Revenue by Geographic Area in 2024
5.2.8 ERT Recent Developments
5.3 McLaren
5.3.1 McLaren Corporation Information
5.3.2 McLaren Description, Business Overview
5.3.3 McLaren Clinical Trial Imaging Products Offered
5.3.4 McLaren Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.3.5 McLaren Clinical Trial Imaging Revenue by Product in 2024
5.3.6 McLaren Clinical Trial Imaging Revenue by Application in 2024
5.3.7 McLaren Clinical Trial Imaging Revenue by Geographic Area in 2024
5.3.8 McLaren Recent Developments
5.4 Bioclinica
5.4.1 Bioclinica Corporation Information
5.4.2 Bioclinica Description, Business Overview
5.4.3 Bioclinica Clinical Trial Imaging Products Offered
5.4.4 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.4.5 Bioclinica Clinical Trial Imaging Revenue by Product in 2024
5.4.6 Bioclinica Clinical Trial Imaging Revenue by Application in 2024
5.4.7 Bioclinica Clinical Trial Imaging Revenue by Geographic Area in 2024
5.4.8 Bioclinica Recent Developments
5.5 Parexel
5.5.1 Parexel Corporation Information
5.5.2 Parexel Description, Business Overview
5.5.3 Parexel Clinical Trial Imaging Products Offered
5.5.4 Parexel Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.5.5 Parexel Clinical Trial Imaging Revenue by Product in 2024
5.5.6 Parexel Clinical Trial Imaging Revenue by Application in 2024
5.5.7 Parexel Clinical Trial Imaging Revenue by Geographic Area in 2024
5.5.8 Parexel Recent Developments
5.6 BioTelemetry
5.6.1 BioTelemetry Corporation Information
5.6.2 BioTelemetry Description, Business Overview
5.6.3 BioTelemetry Clinical Trial Imaging Products Offered
5.6.4 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.6.5 BioTelemetry Clinical Trial Imaging Revenue by Product in 2024
5.6.6 BioTelemetry Clinical Trial Imaging Revenue by Application in 2024
5.6.7 BioTelemetry Clinical Trial Imaging Revenue by Geographic Area in 2024
5.6.8 BioTelemetry Recent Developments
5.7 ProScan Imaging
5.7.1 ProScan Imaging Corporation Information
5.7.2 ProScan Imaging Description, Business Overview
5.7.3 ProScan Imaging Clinical Trial Imaging Products Offered
5.7.4 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.7.5 ProScan Imaging Clinical Trial Imaging Revenue by Product in 2024
5.7.6 ProScan Imaging Clinical Trial Imaging Revenue by Application in 2024
5.7.7 ProScan Imaging Clinical Trial Imaging Revenue by Geographic Area in 2024
5.7.8 ProScan Imaging Recent Developments
5.8 Imaging Endpoints
5.8.1 Imaging Endpoints Corporation Information
5.8.2 Imaging Endpoints Description, Business Overview
5.8.3 Imaging Endpoints Clinical Trial Imaging Products Offered
5.8.4 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.8.5 Imaging Endpoints Clinical Trial Imaging Revenue by Product in 2024
5.8.6 Imaging Endpoints Clinical Trial Imaging Revenue by Application in 2024
5.8.7 Imaging Endpoints Clinical Trial Imaging Revenue by Geographic Area in 2024
5.8.8 Imaging Endpoints Recent Developments
5.9 Radiant Sage
5.9.1 Radiant Sage Corporation Information
5.9.2 Radiant Sage Description, Business Overview
5.9.3 Radiant Sage Clinical Trial Imaging Products Offered
5.9.4 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.9.5 Radiant Sage Clinical Trial Imaging Revenue by Product in 2024
5.9.6 Radiant Sage Clinical Trial Imaging Revenue by Application in 2024
5.9.7 Radiant Sage Clinical Trial Imaging Revenue by Geographic Area in 2024
5.9.8 Radiant Sage Recent Developments
5.10 Micron, Inc.
5.10.1 Micron, Inc. Corporation Information
5.10.2 Micron, Inc. Description, Business Overview
5.10.3 Micron, Inc. Clinical Trial Imaging Products Offered
5.10.4 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.10.5 Micron, Inc. Clinical Trial Imaging Revenue by Product in 2024
5.10.6 Micron, Inc. Clinical Trial Imaging Revenue by Application in 2024
5.10.7 Micron, Inc. Clinical Trial Imaging Revenue by Geographic Area in 2024
5.10.8 Micron, Inc. Recent Developments
5.11 Intrinsic Imaging
5.11.1 Intrinsic Imaging Corporation Information
5.11.2 Intrinsic Imaging Description, Business Overview
5.11.3 Intrinsic Imaging Clinical Trial Imaging Products Offered
5.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.11.5 Intrinsic Imaging Clinical Trial Imaging Revenue by Product in 2024
5.11.6 Intrinsic Imaging Clinical Trial Imaging Revenue by Application in 2024
5.11.7 Intrinsic Imaging Clinical Trial Imaging Revenue by Geographic Area in 2024
5.11.8 Intrinsic Imaging Recent Developments
5.12 Median Technologies
5.12.1 Median Technologies Corporation Information
5.12.2 Median Technologies Description, Business Overview
5.12.3 Median Technologies Clinical Trial Imaging Products Offered
5.12.4 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.12.5 Median Technologies Clinical Trial Imaging Revenue by Product in 2024
5.12.6 Median Technologies Clinical Trial Imaging Revenue by Application in 2024
5.12.7 Median Technologies Clinical Trial Imaging Revenue by Geographic Area in 2024
5.12.8 Median Technologies Recent Developments
5.13 Cardiovascular Imaging Technologies
5.13.1 Cardiovascular Imaging Technologies Corporation Information
5.13.2 Cardiovascular Imaging Technologies Description, Business Overview
5.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products Offered
5.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.13.5 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Product in 2024
5.13.6 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Application in 2024
5.13.7 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue by Geographic Area in 2024
5.13.8 Cardiovascular Imaging Technologies Recent Developments
5.14 Banook Medical
5.14.1 Banook Medical Corporation Information
5.14.2 Banook Medical Description, Business Overview
5.14.3 Banook Medical Clinical Trial Imaging Products Offered
5.14.4 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.14.5 Banook Medical Clinical Trial Imaging Revenue by Product in 2024
5.14.6 Banook Medical Clinical Trial Imaging Revenue by Application in 2024
5.14.7 Banook Medical Clinical Trial Imaging Revenue by Geographic Area in 2024
5.14.8 Banook Medical Recent Developments
5.15 IXICO
5.15.1 IXICO Corporation Information
5.15.2 IXICO Description, Business Overview
5.15.3 IXICO Clinical Trial Imaging Products Offered
5.15.4 IXICO Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.15.5 IXICO Clinical Trial Imaging Revenue by Product in 2024
5.15.6 IXICO Clinical Trial Imaging Revenue by Application in 2024
5.15.7 IXICO Clinical Trial Imaging Revenue by Geographic Area in 2024
5.15.8 IXICO Recent Developments
5.16 Tigermed
5.16.1 Tigermed Corporation Information
5.16.2 Tigermed Description, Business Overview
5.16.3 Tigermed Clinical Trial Imaging Products Offered
5.16.4 Tigermed Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.16.5 Tigermed Clinical Trial Imaging Revenue by Product in 2024
5.16.6 Tigermed Clinical Trial Imaging Revenue by Application in 2024
5.16.7 Tigermed Clinical Trial Imaging Revenue by Geographic Area in 2024
5.16.8 Tigermed Recent Developments
5.17 Runda Medical
5.17.1 Runda Medical Corporation Information
5.17.2 Runda Medical Description, Business Overview
5.17.3 Runda Medical Clinical Trial Imaging Products Offered
5.17.4 Runda Medical Clinical Trial Imaging Revenue and Gross Margin (2020-2025)
5.17.5 Runda Medical Clinical Trial Imaging Revenue by Product in 2024
5.17.6 Runda Medical Clinical Trial Imaging Revenue by Application in 2024
5.17.7 Runda Medical Clinical Trial Imaging Revenue by Geographic Area in 2024
5.17.8 Runda Medical Recent Developments
6 North America
6.1 North America Clinical Trial Imaging Market Size YoY Growth 2020-2031
6.2 North America Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
6.3 North America Clinical Trial Imaging Revenue by Type (2020-2025)
6.4 North America Clinical Trial Imaging Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Clinical Trial Imaging Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Clinical Trial Imaging Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Clinical Trial Imaging Revenue by Type (2020-2025)
7.4 Asia-Pacific Clinical Trial Imaging Revenue by Application (2020-2025)
8 Europe
8.1 Europe Clinical Trial Imaging Market Size YoY Growth 2020-2031
8.2 Europe Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
8.3 Europe Clinical Trial Imaging Revenue by Type (2020-2025)
8.4 Europe Clinical Trial Imaging Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Clinical Trial Imaging Market Size YoY Growth 2020-2031
9.2 Latin America Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
9.3 Latin America Clinical Trial Imaging Revenue by Type (2020-2025)
9.4 Latin America Clinical Trial Imaging Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Clinical Trial Imaging Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Clinical Trial Imaging Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Clinical Trial Imaging Revenue by Type (2020-2025)
10.4 Middle East and Africa Clinical Trial Imaging Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Clinical Trial Imaging Supply Chain Analysis
11.2 Clinical Trial Imaging Key Raw Materials and Upstream Suppliers
11.3 Clinical Trial Imaging Clients Analysis
11.4 Clinical Trial Imaging Sales Channel and Sales Model Analysis
11.4.1 Clinical Trial Imaging Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Clinical Trial Imaging Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Clinical Trial Imaging Distributors
12 Clinical Trial Imaging Market Dynamics
12.1 Clinical Trial Imaging Industry Trends
12.2 Clinical Trial Imaging Market Drivers
12.3 Clinical Trial Imaging Market Challenges
12.4 Clinical Trial Imaging Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Clinical Trial Imaging Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Clinical Trial Imaging Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Clinical Trial Imaging Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Clinical Trial Imaging Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Clinical Trial Imaging Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Clinical Trial Imaging Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Clinical Trial Imaging Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)
Table 11. Clinical Trial Imaging Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Clinical Trial Imaging Players by Revenue (US$ Million) in 2024
Table 13. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Clinical Trial Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
Table 15. Global Clinical Trial Imaging Companies Headquarters
Table 16. Date of International Companies Enter into Clinical Trial Imaging Market
Table 17. Global Clinical Trial Imaging Companies Product & Service
Table 18. Global Clinical Trial Imaging Mergers & Acquisitions, Expansion Plans
Table 19. ICON Corporation Information
Table 20. ICON Description and Business Overview
Table 21. ICON Clinical Trial Imaging Product
Table 22. ICON Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. ICON Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 24. ICON Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 25. ICON Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 26. ICON Recent Developments
Table 27. ERT Corporation Information
Table 28. ERT Description and Business Overview
Table 29. ERT Clinical Trial Imaging Product
Table 30. ERT Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. ERT Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 32. ERT Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 33. ERT Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 34. ERT Recent Developments
Table 35. McLaren Corporation Information
Table 36. McLaren Description and Business Overview
Table 37. McLaren Clinical Trial Imaging Product
Table 38. McLaren Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. McLaren Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 40. McLaren Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 41. McLaren Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 42. McLaren Recent Developments
Table 43. Bioclinica Corporation Information
Table 44. Bioclinica Description and Business Overview
Table 45. Bioclinica Clinical Trial Imaging Product
Table 46. Bioclinica Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bioclinica Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 48. Bioclinica Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 49. Bioclinica Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 50. Bioclinica Recent Developments
Table 51. Parexel Corporation Information
Table 52. Parexel Description and Business Overview
Table 53. Parexel Clinical Trial Imaging Product
Table 54. Parexel Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Parexel Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 56. Parexel Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 57. Parexel Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 58. Parexel Recent Developments
Table 59. BioTelemetry Corporation Information
Table 60. BioTelemetry Description and Business Overview
Table 61. BioTelemetry Clinical Trial Imaging Product
Table 62. BioTelemetry Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 64. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 65. BioTelemetry Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 66. BioTelemetry Recent Developments
Table 67. ProScan Imaging Corporation Information
Table 68. ProScan Imaging Description and Business Overview
Table 69. ProScan Imaging Clinical Trial Imaging Product
Table 70. ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 72. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 73. ProScan Imaging Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 74. ProScan Imaging Recent Developments
Table 75. Imaging Endpoints Corporation Information
Table 76. Imaging Endpoints Description and Business Overview
Table 77. Imaging Endpoints Clinical Trial Imaging Product
Table 78. Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 80. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 81. Imaging Endpoints Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 82. Imaging Endpoints Recent Developments
Table 83. Radiant Sage Corporation Information
Table 84. Radiant Sage Description and Business Overview
Table 85. Radiant Sage Clinical Trial Imaging Product
Table 86. Radiant Sage Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 88. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 89. Radiant Sage Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 90. Radiant Sage Recent Developments
Table 91. Micron, Inc. Corporation Information
Table 92. Micron, Inc. Description and Business Overview
Table 93. Micron, Inc. Clinical Trial Imaging Product
Table 94. Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 96. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 97. Micron, Inc. Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 98. Micron, Inc. Recent Developments
Table 99. Intrinsic Imaging Corporation Information
Table 100. Intrinsic Imaging Description and Business Overview
Table 101. Intrinsic Imaging Clinical Trial Imaging Product
Table 102. Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 104. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 105. Intrinsic Imaging Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 106. Intrinsic Imaging Recent Developments
Table 107. Median Technologies Corporation Information
Table 108. Median Technologies Description and Business Overview
Table 109. Median Technologies Clinical Trial Imaging Product
Table 110. Median Technologies Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Median Technologies Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 112. Median Technologies Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 113. Median Technologies Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 114. Median Technologies Recent Developments
Table 115. Cardiovascular Imaging Technologies Corporation Information
Table 116. Cardiovascular Imaging Technologies Description and Business Overview
Table 117. Cardiovascular Imaging Technologies Clinical Trial Imaging Product
Table 118. Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 120. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 121. Cardiovascular Imaging Technologies Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 122. Cardiovascular Imaging Technologies Recent Developments
Table 123. Banook Medical Corporation Information
Table 124. Banook Medical Description and Business Overview
Table 125. Banook Medical Clinical Trial Imaging Product
Table 126. Banook Medical Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Banook Medical Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 128. Banook Medical Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 129. Banook Medical Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 130. Banook Medical Recent Developments
Table 131. IXICO Corporation Information
Table 132. IXICO Description and Business Overview
Table 133. IXICO Clinical Trial Imaging Product
Table 134. IXICO Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. IXICO Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 136. IXICO Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 137. IXICO Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 138. IXICO Recent Developments
Table 139. Tigermed Corporation Information
Table 140. Tigermed Description and Business Overview
Table 141. Tigermed Clinical Trial Imaging Product
Table 142. Tigermed Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Tigermed Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 144. Tigermed Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 145. Tigermed Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 146. Tigermed Recent Developments
Table 147. Runda Medical Corporation Information
Table 148. Runda Medical Description and Business Overview
Table 149. Runda Medical Clinical Trial Imaging Product
Table 150. Runda Medical Clinical Trial Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Runda Medical Revenue Proportion of Clinical Trial Imaging by Product in 2024
Table 152. Runda Medical Revenue Proportion of Clinical Trial Imaging by Application in 2024
Table 153. Runda Medical Revenue Proportion of Clinical Trial Imaging by Geographic Area in 2024
Table 154. Runda Medical Recent Developments
Table 155. North America Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
Table 156. North America Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
Table 157. North America Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 158. North America Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 159. Asia-Pacific Clinical Trial Imaging Revenue by Region (2020-2025) & (US$ Million)
Table 160. Asia-Pacific Clinical Trial Imaging Revenue by Region (2026-2031) & (US$ Million)
Table 161. Asia-Pacific Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 162. Asia-Pacific Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 163. Europe Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
Table 164. Europe Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
Table 165. Europe Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 166. Europe Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 167. Latin America Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
Table 168. Latin America Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
Table 169. Latin America Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 170. Latin America Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 171. Middle East and Africa Clinical Trial Imaging Revenue by Country (2020-2025) & (US$ Million)
Table 172. Middle East and Africa Clinical Trial Imaging Revenue by Country (2026-2031) & (US$ Million)
Table 173. Middle East and Africa Clinical Trial Imaging Revenue by Type (2020-2025) & (US$ Million)
Table 174. Middle East and Africa Clinical Trial Imaging Revenue by Application (2020-2025) & (US$ Million)
Table 175. Clinical Trial Imaging Key Raw Materials, Industry Status and Trend
Table 176. Clinical Trial Imaging Key Raw Materials and Upstream Suppliers
Table 177. Clinical Trial Imaging Clients Status and Trend
Table 178. Clinical Trial Imaging Typical Clients
Table 179. Clinical Trial Imaging Distributors
Table 180. Clinical Trial Imaging Market Trends
Table 181. Clinical Trial Imaging Market Drivers
Table 182. Clinical Trial Imaging Market Challenges
Table 183. Clinical Trial Imaging Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Trial Imaging Product Picture
Figure 2. Global Clinical Trial Imaging Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Clinical Trial Imaging Revenue Market Share by Type in 2024 & 2031
Figure 4. In-house Imaging Service Product Picture
Figure 5. Central Imaging Service Product Picture
Figure 6. Global Clinical Trial Imaging Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Clinical Trial Imaging Revenue Market Share by Application in 2024 & 2031
Figure 8. Pharmaceutical Companies
Figure 9. Biotechnology Companies
Figure 10. Academic Institutes
Figure 11. Others
Figure 12. Clinical Trial Imaging Report Years Considered
Figure 13. Global Clinical Trial Imaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Clinical Trial Imaging Market Size (2020-2031) & (US$ Million)
Figure 15. Global Clinical Trial Imaging Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
Figure 17. Global Clinical Trial Imaging Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Clinical Trial Imaging Revenue Market Share Forecast by Application (2020-2031)
Figure 19. In-house Imaging Service of Clinical Trial Imaging Revenue Market Share by Application, 2024 VS 2031
Figure 20. Central Imaging Service of Clinical Trial Imaging Revenue Market Share by Application, 2024 VS 2031
Figure 21. Clinical Trial Imaging Revenue Share by Company (2024)
Figure 22. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. In-house Imaging Service Revenue Proportion by Company in 2024
Figure 24. Central Imaging Service Revenue Proportion by Company in 2024
Figure 25. North America Clinical Trial Imaging Revenue 2020-2031 (US$ Million)
Figure 26. North America Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
Figure 27. North America Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
Figure 28. Asia-Pacific Clinical Trial Imaging Revenue 2020-2031 (US$ Million)
Figure 29. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Region (2020-2031)
Figure 30. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
Figure 32. Europe Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
Figure 33. Europe Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
Figure 34. Europe Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
Figure 35. Europe Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
Figure 36. Latin America Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Latin America Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
Figure 38. Latin America Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
Figure 39. Latin America Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
Figure 40. Middle East and Africa Clinical Trial Imaging Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Country (2020-2031)
Figure 42. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Type (2020-2025)
Figure 43. Middle East and Africa Clinical Trial Imaging Revenue Market Share by Application (2020-2025)
Figure 44. Clinical Trial Imaging Supply Chain (Upstream and Downstream Market)
Figure 45. Global Production Market Share of Clinical Trial Imaging Raw Materials by Region in 2024
Figure 46. Clinical Trial Imaging Distribution Channels
Figure 47. Global Clinical Trial Imaging Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 48. Global Clinical Trial Imaging Percentage 2020-2031: Online Sales VS Offline Sales
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
